GLP1R and obesity disorder: Early indications of severely lowered diurnal secretion in obesity were obtained with assay for enteroglucagon (crossreacting glucagon antibodies) in people with morbid obesity (38) (see Figure 2), and early measurements of total GLP-1 in obese individuals supported this conclusion (see Figure 3) (39, 40).